Vascularized Composite Allograft Transplantation Committee

The Vascularized Composite Allograft Transplantation (VCA) Committee considers medical, scientific, and ethical aspects related to VCA allocation, procurement, distribution, and transplantation. The Committee considers both the broad implications and the specific member situations related to VCA issues and policies. The goals of the Committee's work are to improve access to VCA transplantation, to develop evidence-based policies for allocating VCAs, and to improve the health outcomes of VCA transplant recipients.

Current projects

Review

• Measuring Transplant Outcomes by Collecting Data on Children Born to Uterus Recipients (6/2020)

Implemented

• Update Guidance on Optimizing VCA Recovery
• Modify Graft Failure Definition for VCA (9/2023)
• Apply Transplant Notification Requirements for VCA Program Inactivation (9/2023)
• Establish Membership Requirements for Uterus Transplant Programs (12/2021)
• Programming VCA Allocation in UNet (9/2023)
• Modify Data Collection on Living VCA Donors (12/2020)
• Update to VCA Transplant Outcomes Data Collection (9/2023)
• Eliminate the use of regions in VCA distribution (1/2019)
• Align VCA program membership requirements with other programs (1/2018)
• List covered body parts for VCA (1/2016)
• Membership Requirements for VCA Transplant Programs (1/2015)

Committee members